AIP
LABU icon

Ahrens Investment Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Ahrens Investment Partners’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$260 Sell
25
-5,360
-100% -$727K ﹤0.01% 982
2022
Q4 		$11.6K Sell
5,385
-6,215
-54% -$867K 0.01% 176
2022
Q3 		$200K Buy
11,600
+8,330
+255% +$1.53M 0.11% 142
2022
Q2 		$83K Buy
+3,270
New +$557K 0.04% 253

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Ahrens Investment Partners's LABU Position: Q1 2023 in Review

Ahrens Investment Partners reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 64% in Q1 2023, selling an estimated $1.53M and leaving 6,303 shares worth $619K. The position accounts for 0.31% of the portfolio, ranked #60.

Ahrens Investment Partners first reported a position in LABU in Q2 2022 and has held it in 4 quarters since. The position peaked at $4.51M in Q3 2022. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Ahrens Investment Partners held 6,303 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $619K as of Q1 2023.
  • Ahrens Investment Partners sold 11,318 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $1.53M.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.31% of Ahrens Investment Partners's portfolio in Q1 2023, its #60 holding.
  • Ahrens Investment Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $4.51M in Q3 2022.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.